Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford Nanopore and 4bases collaborate on kit for BRCA1 and BRCA2 gene analysis

March 20, 2023
Medical Communications

Oxford Nanopore Technologies and Swiss company 4bases have announced a collaboration making 4bases kits with Oxford Nanopore’s sequencing technology. These …

News

NICE recommends OXLUMO®▼ (lumasiran) in England as first therapy to treat underlying cause of ultra-rare condition primary hyperoxaluria type 1 (PH1)

March 20, 2023
Business Services

MAIDENHEAD, UK, Monday 20th March 2023 – Alnylam UK Limited, the leading RNA interference (RNAi) therapeutics company, today welcomed a …

News
Press release

New data suggests investigational oral osteoarthritis drug APPA may have a promising senotherapeutic effect with potential in other diseases of ageing

March 20, 2023
Business Services

STEVENAGE, UK, March 20, 2023 – New data* presented at the 2023 Osteoarthritis Research Society International (OARSI) World Congress in …

News
Press release

Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset

March 20, 2023
Business Services

Basel, March 20, 2023 — Novartis today presented new data which underscore the transformational and sustained benefit of Zolgensma® (onasemnogene abeparvovec), …

News
Press release

Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia

March 20, 2023
Business Services

Milan, Italy, March 20, 2023, 07:00 am CET – Newron Pharmaceuticals S.p.A.

News
Press release

Sun Pharma settles at $75m in industry-wide price-fixing case

March 17, 2023
Sales and Marketing

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. …

News

Sanofi to cut insulin prices by 78% starting January 2024

March 17, 2023
Sales and Marketing

French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 …

News

FDA approves Novartis’ Tafinlar and Mekinist combination

March 17, 2023
Medical Communications

The FDA has approved Novartis’ combination therapy, Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of BRAF V600E low-grade glioma …

News

CANbridge Pharmaceuticals reports positive long-term data for glioblastoma multiforme drug

March 17, 2023
Medical Communications

Chinese biopharmaceutical company CANbridge Pharmaceuticals has announced positive long-term follow-up data from its clinical studies into a glioblastoma multiforme (GBM) …

News

Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Nonmetastatic Prostate Cancer

March 17, 2023
Business Services

Addlestone UK, 17 March, 2023 –Astellas Pharma Ltd. (“Astellas”) today announced positive topline results from the Phase 3 EMBARK trial …

News
Press release

Newron to present at the 31st European Congress of Psychiatry

March 17, 2023
Business Services

Milan, Italy, March 17, 2023, 7am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused …

News
Press release

iOnctura announces publication of pioneering research describing the unique biological features of roginolisib

March 16, 2023
Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 16 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …

News
Press release

Great Ormand Street Hospital enters commercial agreement with Leucid Bio

March 16, 2023
Medical Communications

Leucid Bio and Great Ormand Street Hospital NHS Foundation Trust (GOSH) have entered a commercial agreement to manufacture Leucid’s lead …

News

The Association of the British Pharmaceutical Industry suspends Novo Nordisk for two years

March 16, 2023
Sales and Marketing

The Association of the British Pharmaceutical Industry (ABPI) has suspended Danish pharmaceutical company Novo Nordisk after “serious breaches” of the …

News

Seamless Therapeutics launches with $12.5m in financing

March 16, 2023
Research and Development

Seamless Therapeutics, a biotech focusing on the therapeutic potential of gene therapies, has announced it received $12.5m (€11.8m) in seed …

News

Bristol Myers Squibb works with SpaceX to study biomanufacturing in space

March 16, 2023
Medical Communications

It was announced last week that the SpaceX Dragon spacecraft will make its journey to the International Space Station (ISS) …

News

PHARMANOVIA ENTERS INTO AN EXCLUSIVE LICENSING AGREEMENT WITH AETERNA ZENTARIS FOR THE FIRST AND ONLY ORALLY ADMINISTERED APPROVED MEDICINE FOR THE DIAGNOSIS OF GROWTH HORMONE DEFICIENCY IN ADULTS

March 16, 2023
Business Services

BASILDON, UK, 16 MARCH 2023 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the …

News
Press release

Zolgensma®▼ (onasemnogene abeparvovec) receives NICE final draft guidance in presymptomatic babies up to 12 months with spinal muscular atrophy (SMA)

March 16, 2023
Business Services

 London, UK, 16th March 2023 – Novartis Gene Therapies has confirmed that the National Institute for Health and Care Excellence …

News
Press release

Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology

March 16, 2023
Business Services

Boston, Massachusetts, March 16th, 2023 – Aldena Therapeutics Inc. (Aldena) a private biotech company pioneering siRNA-based therapies for dermatological indications, …

News
Press release

Cough medicines containing pholcodine withdrawn across UK

March 15, 2023
Medical Communications

Some cough syrups being sold behind the counter at pharmacies are being withdrawn due to safety concerns surrounding potential allergies …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026